Health Care

Filter By:



Research Team

Use comma-separated ID numbers for each author

Support the Hoover Institution

Join the Hoover Institution's community of supporters in advancing ideas defining a free society.

Support Hoover

In the News

Uninsured Rate Rises For The 1st Time Since ACA

quoting Lanhee J. Chenvia Healthcare Drive
Tuesday, September 10, 2019

Though the uninsured rate fluctuates throughout the year, 2018 saw the first annual increase in the number of uninsured Americans in almost a decade amid Trump administration actions that have destabilized the Affordable Care Act and cut enrollment in safety net programs.

In the News

After Repeal And Replace: The Fair Care Act And The 2020 Campaign Plans

mentioning Lanhee J. Chenvia American Enterprise Institute
Tuesday, September 10, 2019

Event: The Trump administration and Republicans in Congress failed to repeal and replace the Affordable Care Act in 2017. So what comes next?

In the News

Green Tyranny And The Tragedy Of The Eco-Commons

quoting Thomas Sowellvia American Thinker
Wednesday, September 4, 2019

"The tragedy of the commons" is a phrase that describes the societal loss of resources through individual selfishness.  In agrarian cultures, sheep, cows or other animals were often maintained in a "commons" where individual farm families would use large shared areas to pasture animals collectively.  This worked well, unless an individual farmer exceeded the carrying capacity of the common to increase his personal wealth -- and if all the farmers did that, the common would be destroyed.

Bad Medicine: The Value Of Monitoring Banned Drugs

by Chirantan Chatterjee
Wednesday, August 28, 2019

These are tough times around the world when it comes to regulating flawed medicines that are banned from the marketplace. Last month, the Washington Post reported details from a DEA database of 76 billion opioid pills sold in the United States between 2006 and 2012, showing that some six companies distributed 75 percent of the pills during that period.

Policy BriefsFeatured

Lanhee Chen On Competition In The Health Insurance Market

by Lanhee J. Chenvia PolicyEd
Thursday, August 22, 2019

Competition among insurers has gone down and premiums have gone up as a result of Obamacare.

Blank Section (Placeholder)Featured

Area 45: Michael Boskin Discusses The Left’s Agenda

interview with Michael J. Boskinvia Area 45
Wednesday, August 21, 2019

Are Democratic hopefuls offering sound ideas (Green New Deal, Universal Basic Income, Medicare-For-All) or economic illiteracy?


Boot Camp Prepares Students For Policy-Making Roles

Monday, August 26, 2019
Hoover Institution, Stanford University

A look at the 2019 Summer Policy Boot Camp.

In the News

Why Milton Friedman Rightly Opposed Drug Policy

quoting Richard A. Epsteinvia Town Hall
Monday, August 19, 2019

"The issue is patents," Nobel-prize winning economist Milton Friedman explained when asked in 2004 why he opposed drug reimportation, the practice of bringing back prescription drugs originally manufactured in the U.S. and exported to other countries to sale. 


Trump's Push To Make Health Care Prices More Transparent Is Long Overdue

by Scott W. Atlasvia CNN Business
Monday, August 19, 2019

The Trump administration is trying to institute a dose of free market reform that promises to disrupt American health care. In a flurry of pro-consumer moves, improving price transparency has been at the center of the administration's plan to reduce the cost of health care through competition.

Policy InsightsFeatured

Single-Payer Health Care

by Scott W. Atlas, Richard A. Epstein, Lee Ohanian, Lanhee J. Chen, Tom Churchvia PolicyEd
Thursday, August 15, 2019

Single-payer health care is when the government acts as the only payer of health care costs in the economy. Rather than individuals purchasing insurance for payment of medical expenses through their employer or on the open market, the federal government typically covers all such costs.


Health Care Policy Working Group

The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.